LivaNova (LIVN) Receivables (2015 - 2026)
LivaNova (LIVN) reported Receivables of $229.3 million for Q1 2026, up 13.4% on a YoY basis from $202.2 million in Q1 2025, and up 5.86% sequentially from $216.6 million in Q4 2025.
LivaNova (LIVN) Receivables (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Receivables data on file, last reported at $229.3 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 13.4% year-over-year to $229.3 million; the trailing twelve-month figure through Mar 2026 stood at $229.3 million (up 13.4% YoY), and the FY2025 full-year result was $216.6 million, up 9.24% from the prior year.
- Receivables improved to $229.3 million in Q1 2026, from $216.6 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $229.8 million in Q2 2025 to a low of $172.1 million in Q3 2022.
- A 5-year average of $198.6 million and a median of $197.2 million in 2024 frame the typical range for Receivables.
- Across the five-year window, Receivables increased 17.46% in 2023 and fell 8.65% in 2024, its largest moves.
- Tracing LIVN's Receivables over 5 years: stood at $183.1 million in 2022, then gained by 17.46% to $215.1 million in 2023, then retreated by 8.65% to $196.5 million in 2024, then gained by 10.24% to $216.6 million in 2025, then climbed by 5.86% to $229.3 million in 2026.
- Business Quant data shows LIVN's Receivables at $229.3 million in Q1 2026, $216.6 million in Q4 2025, and $211.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 229.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.27 Mn |
| Dec 31, 2025 | 216.59 Mn |
| Sep 30, 2025 | 211.58 Mn |
| Jun 30, 2025 | 229.80 Mn |
| Mar 31, 2025 | 202.18 Mn |
| Dec 31, 2024 | 196.46 Mn |
| Sep 30, 2024 | 197.16 Mn |
| Jun 30, 2024 | 200.89 Mn |
| Mar 31, 2024 | 209.43 Mn |
| Dec 31, 2023 | 215.07 Mn |
| Sep 30, 2023 | 189.87 Mn |
| Jun 30, 2023 | 185.88 Mn |
| Mar 31, 2023 | 178.32 Mn |
| Dec 31, 2022 | 183.11 Mn |
| Sep 30, 2022 | 172.09 Mn |
| Jun 30, 2022 | 176.95 Mn |
| Mar 31, 2022 | 182.11 Mn |
| Dec 31, 2021 | 185.35 Mn |
| Sep 30, 2021 | 182.01 Mn |
| Jun 30, 2021 | 182.18 Mn |